Menü Kapat

Evaluation of adropin and clusterin levels in patients with Sjögren’s syndrome

Original Article

Evaluation of adropin and clusterin levels in patients with Sjögren's syndrome

Receiving Date: 02 November 2021

Accept Date: 02 April 2022

Available Online: 13.06.2022

doi: 10.5455/medscience. 2021.10.358

Medicine Science 2022;11(3):944-7

Conflict of interests: The authors declare that there is no conflict of interest in the study.
Financial Disclosure: The authors declare that they have received no financial support for the study.
Ethical approval: The study approval was taken from the local ethics committee of Selcuk University Faculty of Medicine (Approval date and number: 04.03.2021/2021-114).
Author Contributions: The contribution of both authors was equal in reviewing the literatüre, designing the study, being prepared for the ethics committee, and analyzing and reporting the data.

Figure 1. ROC (Receiver operating characteristic) analyses for adropin and clusterin

 2,588 total views,  7 views today

Akdag T, Tezcan D, Unlu A, et al. Evaluation of adropin and clusterin levels in patients with Sjögren’s syndrome. Med Science. 2022;11(3): 944-7.

⇓ PlumX Meter

Corresponding Author: Turan Akdag, Necmettin Erbakan University, Meram Vocational School, Department of Herbal and Animal Production, Konya, Turkey
E-mail: turanakdag570@gmail.com